TrialHealth technology assessment (Winchester, England)2021

Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Philip Hykin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.